|
|
| | 5-Bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine Basic information |
| Product Name: | 5-Bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine | | Synonyms: | 5-Bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine;7-bromo-5-chloro-2,4,9-triazabicyclo[4.3.0]nona-2,4,7,10-tetraene;5-Bromo-4-chloro-7H-pyrrolo[2,3-D]pyrimidine ,98%;5-Bromo-4-chloro-7H-pyrro...;5-broMo-4-chloro-7H-pyrrolo[2;7H-Pyrrolo[2,3-d]pyrimidine, 5-bromo-4-chloro-;7-BroMo-6-chloro-7-deazapurine;5-bromo-4-chloro-1H-pyrrolo[2,3-d]pyrimidine | | CAS: | 22276-95-5 | | MF: | C6H3BrClN3 | | MW: | 232.47 | | EINECS: | 622-419-3 | | Product Categories: | Heterocycle-Pyrimidine series;CHIRAL CHEMICALS | | Mol File: | 22276-95-5.mol | ![5-Bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine Structure](CAS/GIF/22276-95-5.gif) |
| | 5-Bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine Chemical Properties |
| Melting point | 221-225℃ | | Boiling point | 221.0±50.0 °C(Predicted) | | density | 2.15±0.1 g/cm3(Predicted) | | storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | form | solid | | pka | 9.43±0.20(Predicted) | | color | Yellow | | Water Solubility | Slightly soluble in water. | | InChI | InChI=1S/C6H3BrClN3/c7-3-1-9-6-4(3)5(8)10-2-11-6/h1-2H,(H,9,10,11) | | InChIKey | OXLMTRZWMHIZBY-UHFFFAOYSA-N | | SMILES | C1=NC(Cl)=C2C(Br)=CNC2=N1 | | CAS DataBase Reference | 22276-95-5 |
| Hazard Codes | Xn | | Risk Statements | 22 | | RIDADR | 2811 | | WGK Germany | 3 | | HazardClass | 6.1 | | HazardClass | IRRITANT | | PackingGroup | Ⅲ | | HS Code | 2933599590 | | Storage Class | 6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects | | Hazard Classifications | Acute Tox. 3 Oral |
| | 5-Bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine Usage And Synthesis |
| Uses | It is an important raw material and intermediate used in organic synthesis, pharmaceuticals, agrochemicals and dyestuff. | | Synthesis | 4-chloro-7H-pyrrolo[2,3-d]pyrimidine (30 g/0.02 mol) was dissolved in 75 mL of chloroform, followed by added 3.5 g (0.02 mol) of N-bromosuccinamide. The resulting mixture was refluxed for 1 h. After cooling to room temperature, the precipitate was removed by filtration and dried under reduced pressure to afford 5-Bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine.
![5-Bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine](/NewsImg/2023-10-16/6383304681021769691683764.jpg "5-Bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine") | | References | [1] Organic Letters, 2003, vol. 5, # 20, p. 3587 - 3590
[2] Synthesis, 2011, # 9, p. 1442 - 1446
[3] Archiv der Pharmazie, 2016, vol. 349, # 5, p. 356 - 362
[4] European Journal of Medicinal Chemistry, 2017, vol. 138, p. 543 - 551
[5] Patent: CN107556318, 2018, A. Location in patent: Paragraph 0101-0103; 0106; 0107 |
| | 5-Bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine Preparation Products And Raw materials |
|